Efficacy and safety of APO866 in patients with refractory or relapsed cutaneous T-cell lymphoma: a phase 2 clinical trial
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
March 23, 2016
|
| In: |
JAMA dermatology
Year: 2016, Volume: 152, Issue: 7, Pages: 837-839 |
| ISSN: | 2168-6084 |
| DOI: | 10.1001/jamadermatol.2016.0401 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1001/jamadermatol.2016.0401 Verlag, Volltext: https://jamanetwork.com/journals/jamadermatology/fullarticle/2502283 
|
| Author Notes: | Simone M. Goldinger, MD, Sharon Gobbi Bischof, MD, Regina Fink-Puches, MD, Claus-Detlev Klemke, MD, Brigitte Dréno, MD, Martine Bagot, MD, Reinhard Dummer, MD |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1668736896 | ||
| 003 | DE-627 | ||
| 005 | 20220816184745.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190708s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jamadermatol.2016.0401 |2 doi | |
| 035 | |a (DE-627)1668736896 | ||
| 035 | |a (DE-599)KXP1668736896 | ||
| 035 | |a (OCoLC)1341233156 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Goldinger, Simone M. |e VerfasserIn |0 (DE-588)1059230828 |0 (DE-627)798164743 |0 (DE-576)415234263 |4 aut | |
| 245 | 1 | 0 | |a Efficacy and safety of APO866 in patients with refractory or relapsed cutaneous T-cell lymphoma |b a phase 2 clinical trial |c Simone M. Goldinger, MD, Sharon Gobbi Bischof, MD, Regina Fink-Puches, MD, Claus-Detlev Klemke, MD, Brigitte Dréno, MD, Martine Bagot, MD, Reinhard Dummer, MD |
| 264 | 1 | |c March 23, 2016 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 08.07.2019 | ||
| 700 | 1 | |a Klemke, Claus-Detlev |d 1969- |e VerfasserIn |0 (DE-588)122909615 |0 (DE-627)082229074 |0 (DE-576)293473145 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA dermatology |d Chicago, Ill. : American Medical Association, 2013 |g 152(2016), 7, Seite 837-839 |h Online-Ressource |w (DE-627)736006052 |w (DE-600)2701763-1 |w (DE-576)378725068 |x 2168-6084 |7 nnas |a Efficacy and safety of APO866 in patients with refractory or relapsed cutaneous T-cell lymphoma a phase 2 clinical trial |
| 773 | 1 | 8 | |g volume:152 |g year:2016 |g number:7 |g pages:837-839 |g extent:3 |a Efficacy and safety of APO866 in patients with refractory or relapsed cutaneous T-cell lymphoma a phase 2 clinical trial |
| 856 | 4 | 0 | |u https://doi.org/10.1001/jamadermatol.2016.0401 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://jamanetwork.com/journals/jamadermatology/fullarticle/2502283 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190708 | ||
| 993 | |a Editorial | ||
| 994 | |a 2016 | ||
| 998 | |g 122909615 |a Klemke, Claus-Detlev |m 122909615:Klemke, Claus-Detlev |d 60000 |e 60000PK122909615 |k 0/60000/ |p 4 | ||
| 999 | |a KXP-PPN1668736896 |e 3491884454 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"March 23, 2016","dateIssuedKey":"2016"}],"note":["Gesehen am 08.07.2019"],"physDesc":[{"extent":"3 S."}],"relHost":[{"id":{"issn":["2168-6084"],"eki":["736006052"],"zdb":["2701763-1"]},"pubHistory":["149.2013 -"],"recId":"736006052","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 12.10.17"],"origin":[{"publisherPlace":"Chicago, Ill.","dateIssuedKey":"2013","dateIssuedDisp":"2013-","publisher":"American Medical Association"}],"disp":"Efficacy and safety of APO866 in patients with refractory or relapsed cutaneous T-cell lymphoma a phase 2 clinical trialJAMA dermatology","language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"JAMA dermatology","title_sort":"JAMA dermatology"}],"corporate":[{"display":"American Medical Association","role":"isb"}],"part":{"extent":"3","volume":"152","year":"2016","issue":"7","pages":"837-839","text":"152(2016), 7, Seite 837-839"}}],"title":[{"subtitle":"a phase 2 clinical trial","title_sort":"Efficacy and safety of APO866 in patients with refractory or relapsed cutaneous T-cell lymphoma","title":"Efficacy and safety of APO866 in patients with refractory or relapsed cutaneous T-cell lymphoma"}],"person":[{"role":"aut","display":"Goldinger, Simone M.","given":"Simone M.","family":"Goldinger"},{"given":"Claus-Detlev","family":"Klemke","display":"Klemke, Claus-Detlev","role":"aut"}],"recId":"1668736896","language":["eng"],"name":{"displayForm":["Simone M. Goldinger, MD, Sharon Gobbi Bischof, MD, Regina Fink-Puches, MD, Claus-Detlev Klemke, MD, Brigitte Dréno, MD, Martine Bagot, MD, Reinhard Dummer, MD"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1001/jamadermatol.2016.0401"],"eki":["1668736896"]}} | ||
| SRT | |a GOLDINGERSEFFICACYAN2320 | ||